Valsartan-hctz 160-12.5 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB25FJT37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,983
Award facts
- Contract value 100% obligated
- $7,983.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a 90-count quantity. This firm fixed price delivery order, valued at $7,983.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. The contract was awarded without set-aside designation through competitive procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 4, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the DLA Medical Supply Chain demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains. This particular delivery order for Valsartan-HCTZ—an antihypertensive medication combining a valsartan ARB with a thiazide diuretic—reflects AmerisourceBergen's ongoing role in supporting Defense Health Agency and other federal healthcare system requirements for essential medications.
Quick answers
Who was awarded contract SPE2DB25FJT37?
SPE2DB25FJT37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FJT37 worth?
The government has obligated $7,983 on SPE2DB25FJT37.
Is contract SPE2DB25FJT37 an order under another contract?
Yes. SPE2DB25FJT37 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT37 competed?
The extent of competition for SPE2DB25FJT37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award